References
- Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 2011;117:1834–1839.
- El-Mallawany NK, Geller L, Bollard CM, et al. Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant. 2011;46:759–761.
- Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;6262(25 Suppl):D34–D41.
- del Cerro Marin MJ, Sabate Rotes A, Rodriguez Ogando A, et al. Assessing pulmonary hypertensive vascular disease in childhood. data from the spanish registry. Am J Respir Crit Care Med. 2014;190:1421–1429.
- Lantuejoul S, Sheppard MN, Corrin B, et al. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol. 2006;30:850–857.
- Resten A, Maitre S, Humbert M, et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR Am J Roentgenol. 2004;183:65–70.
- Montani D, Achouh L, Dorfmuller P, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore). 2008;87:220–233.
- Montani D, Lau EM, Dorfmuller P, et al. Pulmonary veno-occlusive disease. Eur Respir J. 2016;47:1518–1534.
- Chaisson NF, Dodson MW, Elliott CG. Pulmonary capillary hemangiomatosis and pulmonary veno-occlusive disease. Clin Chest Med. 2016;37:523–534.
- Mukai M, Kondo M, Bohgaki T, et al. Pulmonary veno-occlusive disease following allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia. Br J Haematol. 2003;123:1.
- Or R, Nagler A, Elad S, et al. Noncardiogenic pulmonary congestion following bone marrow transplantation. Respiration. 1997;64:170–172.
- Trobaugh-Lotrario AD, Greffe B, Deterding R, et al. Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review. J Pediatr Hematol Oncol. 2003;25:405–409.
- Bunte MC, Patnaik MM, Pritzker MR, et al. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: A rare model of endothelial dysfunction. Bone Marrow Transplant. 2008;41:677–686.
- Runo JR, Vnencak-Jones CL, Prince M, et al. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med. 2003;167:889–894.
- Hackman RC, Madtes DK, Petersen FB, et al. Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation. 1989;47:989–992.
- Kuga T, Kohda K, Hirayama Y, et al. Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia. Int J Hematol. 1996;64:143–150.
- Salzman D, Adkins DR, Craig F, et al. Malignancy-associated pulmonary veno-occlusive disease: Report of a case following autologous bone marrow transplantation and review. Bone Marrow Transplant. 1996;18:755–760.
- Seguchi M, Hirabayashi N, Fujii Y, et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation. 2000;69:177–179.
- Troussard X, Bernaudin JF, Cordonnier C, et al. Pulmonary veno-occlusive disease after bone marrow transplantation. Thorax. 1984;39:956–957.
- Williams LM, Fussell S, Veith RW, et al. Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature. Chest. 1996;109:1388–1391.
- Hosokawa K, Yamazaki H, Nishitsuji M, et al. Pulmonary veno-occlusive disease following reduced-intensity allogeneic bone marrow transplantation for acute myeloid leukemia. Intern Med. 2012;51:195–198.
- Gutman JA, Allen CT, Madtes DK, et al. Pulmonary veno-occlusive disease following reduced-intensity cord blood transplantation. Bone Marrow Transplant. 2008;42:559–561.
- Bruckmann C, Lindner W, Roos R, et al. Severe pulmonary vascular occlusive disease following bone marrow transplantation in omenn syndrome. Eur J Pediatr. 1991;150:242–245.
- Malhotra P, Varma S, Varma N, et al. Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation. Am J Hematol. 2005;80:164–165.
- Steward CG, Pellier I, Mahajan A, et al. Severe pulmonary hypertension: A frequent complication of stem cell transplantation for malignant infantile osteopetrosis. Br J Haematol. 2004;124:63–71.
- Ranchoux B, Gunther S, Quarck R, et al. Chemotherapy-induced pulmonary hypertension: Role of alkylating agents. Am J Pathol. 2015;185:356–371.
- Jodele S, Hirsch R, Laskin B, et al. Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Biol Blood Marrow Transplant. 2013;19:202–207.
- Dandoy CE, Davies SM, Hirsch R, et al. Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy. Biol Blood Marrow Transplant. 2015;21:113–118.